Welcome to our dedicated page for KNOREX LTD. SEC filings (Ticker: KNRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The KNOREX Ltd. (NYSE American: KNRX) SEC filings page provides access to the company’s official regulatory disclosures as a foreign private issuer. KNOREX files with the U.S. Securities and Exchange Commission under file number 001-42862, and its submissions include documents that explain its financial condition, operations, and corporate developments.
Among the key filings are Form F-1, which KNOREX used in connection with its initial public offering of Class A ordinary shares, and recurring Form 6-K reports. The company has furnished unaudited condensed consolidated financial statements for periods such as the six months ended June 30, 2025, along with operating and financial reviews and accompanying press releases. These materials provide detail on revenue trends, business performance, and management’s discussion of results.
KNOREX’s filings also cover corporate governance and audit matters. In one Form 6-K, the company disclosed a change in its independent registered public accounting firm, describing the dismissal of its prior auditor, the appointment of a new auditor, and the prior auditor’s reports, which included an emphasis of going concern uncertainty. The filing further addressed the absence of reportable disagreements or reportable events as defined under SEC rules.
Through Stock Titan, users can view KNOREX’s SEC filings as they are made available on EDGAR, and benefit from AI-powered summaries that highlight the most important points in lengthy documents. This includes quick insights into interim financial statements, narrative reviews, and other exhibits. For investors researching KNRX, these filings offer a primary source of information on the company’s financial reporting, risk disclosures, and key corporate actions.
KNOREX Ltd. reported that its Board of Directors has appointed Ning (Michael) Sun as Chief Financial Officer, effective January 22, 2026. The company says this move is intended to strengthen its executive team and financial leadership as it builds internal infrastructure for its next phase of growth as a public company.
Sun previously served as KNOREX’s Head of Capital Markets, overseeing capital markets planning, investor engagement, and pre-IPO initiatives. His background includes senior roles at U.S.-listed companies Jiayin Group and Fang Holdings, as well as earlier experience at Davis Polk & Wardwell LLP in Beijing.
KNOREX is a B2B technology company providing AI-driven, cross-channel programmatic advertising solutions through its KNOREX XPO platform, which helps marketers plan, execute, and optimize digital ad campaigns across multiple formats and channels.
Knorex Ltd. disclosed that its Audit Committee dismissed Kreit & Chiu CPA LLP as independent auditor and appointed Assentsure PAC as the new independent registered public accounting firm for the fiscal year ending December 31, 2025. Kreit & Chiu’s audit reports on Knorex’s consolidated financial statements for the years ended December 31, 2024 and 2023 contained no adverse or disclaimed opinions and were not qualified, other than including an emphasis about the company’s going concern uncertainty.
The company reports there were no disagreements or reportable events with the former auditor over accounting principles, financial disclosures, or audit procedures during those periods, and that it did not consult Assentsure on accounting or audit opinions before the appointment.
Franklin Capital Enterprise LtdKnorex Ltd. Class A ordinary shares. The investor beneficially owns 4,387,025 Class A ordinary shares, representing 17.1% of this share class. Franklin Capital has sole power to vote and dispose of all these shares, with no shared voting or dispositive authority reported. This filing indicates that a single institutional holder controls a notable minority position in Knorex’s publicly traded equity.
KNOREX LTD. received a Schedule 13G disclosure showing that Ritz Venture Capital Pte Ltd, a Singapore-based entity, beneficially owns 1,473,300 Class A Ordinary shares, representing 5.7% of the class. Ritz Venture Capital reports sole power to vote and dispose of all these shares, with no shared voting or dispositive power. The filing relates to an event dated 09/29/2025 and indicates that no other persons or groups are reported as having an interest in these shares. The statement is signed by Managing Director SangBin ONG on behalf of Ritz Venture Capital.
Raffles Venture (Direct) Pte. Ltd., a Singapore company, filed a Schedule 13G disclosing a significant passive stake in KNOREX LTD. Class A Ordinary shares. Raffles Venture reports beneficial ownership of 11.92% of the Class A Ordinary shares plus 0.04% through warrants that are exercisable into Class A Ordinary shares, for a total of 11.96% assuming exercise of the warrants.
The firm states it has sole voting and dispositive power over the reported securities and no shared power with other parties. The filing indicates this is not part of a group and that no other person has the right to receive or direct the proceeds or voting of more than 5% of the class on its behalf.